Quest Diagnostics Profile

114.99
USD 1.46  1.29%
100%
95%

Exercise or conversion by Everett Cunningham of 40328 shares of Quest Diagnostics subject to Rule 16b-3

Quest Diagnostics Incorporated insider trading alert for exercise of non-qualifed stock option (right to buy) by Everett Cunningham, SVP Commercial, on July 19, 2018. This event was filed by Quest Diagnostics Inc with SEC on 2018-07-12. Statement of changes in beneficial ownership - SEC Form 4. Everett Cunningham is currently serves as senior vice president - commercial of Quest Diagnostics In [view details]   

Quest Diagnostics Summary

Quest Diagnostics Incorporated (DGX) is traded on BATS Exchange in USA. It is located in NEW JERSEY U.S.A and employs 45,000 people. Quest Diagnostics is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 15.61 B. Quest Diagnostics Incorporated runs under Healthcare sector within Medical Equipment industry. This company has 135.82 M outstanding shares of which 4.62 M shares are currently shorted by investors with about 4.63 days to cover shorted positions. QUEST DIAGNOSTC has about 124 M in cash with 726.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91.
Check Quest Diagnostics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 114.99HorizonTargetOdds Above 114.99
94.98%30 days 114.99 4.84%
Based on normal probability distribution, the odds of Quest Diagnostics to move above current price in 30 days from now is nearly 4.84% (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Diagnostics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares266 K29.2 M
Nn Investment Partners Holdings NvCommon Shares245.5 K27 M
View Quest Diagnostics Diagnostics

Selected Quest Diagnostics Incorporated Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Quest Diagnostics Against Markets

Risk Adjusted
Performance Score (0 to 100)
15 
Chance of
Financial Distress (0 to 100%)
29 
Equity ratings for Quest Diagnostics Incorporated are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in USA and traded on New York Stock Exchange. It employs 45000 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
Quest Diagnostics In SEC Filings
Quest Diagnostics SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameQuest Diagnostics Incorporated
CEOStephen RusckowskiView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
BBB+Good
Specialization
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
RegionNorth America
LocationNEW JERSEY U.S.A
Business Address500 Plaza Drive
ExchangeBATS Exchange
CIK Number0001022079
ISINUS74834L1008
CUSIP74834L100
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.questdiagnostics.com
Phone973 520 2700
CurrencyUSD - US Dollar

Quest Diagnostics Dividends

Upcoming distributions to stockholders

Quest Diagnostics Corporate Directors

Gail Wilensky Independent Director
Jenne Britell Independent Director
Shawn Bevec Executive Director Investor Relations
Additionally see Investing Opportunities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.